Service to be Provided. Consultant shall provide regulatory consulting services related to FDA requirements for submission of Investigational New Drug Applications (INDs) to conduct clinical studies used to support the development and marketing of Client's products.
Appears in 3 contracts
Sources: Consulting Agreement (Phage Therapeutics International Inc), Consulting Agreement (Phage Therapeutics International Inc), Consulting Agreement (Phage Therapeutics International Inc)